Human monoclonal antibodies to dendritic cells

Details for Australian Patent Application No. 2002340451 (hide)

Owner Celldex Therapeutics, Inc.

Inventors Deo, Yashwant M; Treml, John; Endres, Michael; Keler, Tibor

Agent Shelston IP

Pub. Number AU-B-2002340451

PCT Number PCT/US02/36036

PCT Pub. Number WO2003/040169

Priority 10/035,637 07.11.01 US

Filing date 7 November 2002

Wipo publication date 19 May 2003

Acceptance publication date 20 November 2008

International Classifications

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 10/035,637 07.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002340451

20 November 2008 Application Accepted

  Published as AU-B-2002340451

19 March 2009 Standard Patent Sealed

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340452-CHIP-JOIN PROCESS TO REDUCE ELONGATION MISMATCH BETWEEN THE ADHERENTS AND SEMICONDUCTOR PACKAGE MADE THEREBY

2002340450-Methods for vascular imaging using nanoparticulate contrast agents